Antisense Therapy Market Growth in Precision Medicine
The antisense therapy sector is emerging as a transformative segment within nucleic acid-based therapeutics, driven by advancements in genetic research, increasing prevalence of rare and chronic diseases, and rising demand for precision medicine. Antisense oligonucleotide technologies are gaining strong clinical acceptance due to their ability to selectively target disease-causing mRNA...
0 Comments 0 Shares 31 Views 0 Reviews